about
MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell lineDelivery of gene silencing agents for breast cancer therapyNanotechnology in cancer therapyThe ZNF304-integrin axis protects against anoikis in cancerIn silico investigation of potential SRC kinase ligands from traditional Chinese medicinePhase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.Development of nanoscale approaches for ovarian cancer therapeutics and diagnosticsExosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAsNanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.The landscape of kinase fusions in cancerEnhanced gastrointestinal expression of cytosolic malic enzyme (ME1) induces intestinal and liver lipogenic gene expression and intestinal cell proliferation in mice.Src family kinases and paclitaxel sensitivity.Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling.Targeting Src in endometriosis-associated ovarian cancerNanovector delivery of siRNA for cancer therapyGenome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.Assessment of In Vivo siRNA Delivery in Cancer Mouse ModelsTargeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors.Weighted gene co-expression network analysis of gene modules for the prognosis of esophageal cancer.Submicroscopic genomic rearrangements change gene expression in T-cell large granular lymphocyte leukemia.Regulation of prostate cancer immunity-related genes in PC3 prostate cancer cells by ETS-1Traditional Chinese medicine as dual guardians against hypertension and cancer?Chitosan Nanoparticles for miRNA Delivery.Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.Translating chitosan to clinical delivery of nucleic acid-based drugs
P2860
Q21202160-F54139CC-2FF7-4670-9F0E-35A82FD6FDE2Q27008706-7F3FF3E5-37BC-472A-AF06-8AD3A06AF304Q27023013-50E4E592-73DE-45CF-ADA9-72AE11084C91Q28115264-E46A7E4A-DB0E-42B4-817E-E2BF7C89ECD4Q28481644-C3FF68FB-C69A-450D-B060-E91A4E4015BEQ30416923-63F3DCCD-EB97-4190-BA8E-A0C932024E29Q30421664-DFA57DE8-5DF0-4B6C-BF86-856DE7FD1BF9Q30844815-88FBF1FE-B367-41FE-A829-FDC860B472D3Q33935474-40DACE0D-7636-4DAD-AFF8-956D8CD3E57BQ34437602-76D202FB-FE33-44D7-9B8C-A3B408978319Q34526895-5D8E0419-B2A7-4534-8C2B-43ED5FAA14E7Q35214722-94F1E8A8-A2AD-4782-88A8-5289515E957CQ35919774-2C6F678A-D683-4329-9C8B-14D8047609C4Q37224282-31454C2A-A4BC-4865-8F87-DBA08331C96BQ37347097-554F70F2-D1DD-4279-93EE-AC7EC1AAE62DQ37353774-B8676CF4-5C3E-463C-B587-96BA98588B94Q37481788-A30A6E65-99ED-4FA8-9F51-1DE0F3F6055FQ37597360-8B7D411D-6940-451A-ABA3-81B3225C013DQ38148788-F5753135-76BC-4414-83E4-E4EDE48A3EB3Q38432765-F0BD9213-C3C8-4FEC-9DE9-22904B1C719FQ39013585-D24EA13A-7657-47AC-BE8D-EB42EAD8E297Q39323710-C66165C9-D0F3-406D-A1FE-8F42D546F32EQ47197241-BC97A9E2-4846-42B3-80E9-7EDADA8D6E7EQ48715887-C30C5A4D-81B1-4F16-B444-74EA1789BFC7Q50883478-32D56807-1347-4EFF-A114-4E9968AAC329Q57556362-91FC132F-41AE-40B1-959B-CC909CD18920
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Functional roles of Src and Fgr in ovarian carcinoma.
@ast
Functional roles of Src and Fgr in ovarian carcinoma.
@en
Functional roles of Src and Fgr in ovarian carcinoma.
@nl
type
label
Functional roles of Src and Fgr in ovarian carcinoma.
@ast
Functional roles of Src and Fgr in ovarian carcinoma.
@en
Functional roles of Src and Fgr in ovarian carcinoma.
@nl
prefLabel
Functional roles of Src and Fgr in ovarian carcinoma.
@ast
Functional roles of Src and Fgr in ovarian carcinoma.
@en
Functional roles of Src and Fgr in ovarian carcinoma.
@nl
P2093
P2860
P1476
Functional roles of Src and Fgr in ovarian carcinoma
@en
P2093
Alpa M Nick
Anil K Sood
Eun Ji Nam
Gabriel Lopez-Berestein
Gary E Gallick
Hee Dong Han
Hye-Sun Kim
Jeong-Won Lee
Ju-Won Roh
Justin Bottsford-Miller
P2860
P304
P356
10.1158/1078-0432.CCR-10-2081
P407
P577
2011-02-07T00:00:00Z